NF Trinity Capital’s Gilead Sciences GILD Stock Holding History

NF Trinity Capital’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$5.65M	Hold	86,959	–	–	0.9%	26
2018 Q4	$5.44M	Hold	86,959	–	–	0.88%	29
2018 Q3	$6.71M	Hold	86,959	–	–	0.89%	29
2018 Q2	$6.16M	Hold	86,959	–	–	0.84%	29
2018 Q1	$6.56M	Hold	86,959	–	–	0.9%	28
2017 Q4	$6.23M	Hold	86,959	–	–	0.81%	28
2017 Q3	$7.04M	Hold	86,959	–	–	1.01%	27
2017 Q2	$6.16M	Hold	86,959	–	–	0.87%	27
2017 Q1	$5.91M	Hold	86,959	–	–	0.8%	27
2016 Q4	$6.23M	Sell	86,959 -69,020	-44%	-$5.13M	0.88%	26
2016 Q3	$12.3M	Hold	155,979	–	–	1.38%	20
2016 Q2	$13M	Hold	155,979	–	–	1.43%	23
2016 Q1	$14.3M	Hold	155,979	–	–	1.74%	18
2015 Q4	$15.8M	Buy	+155,979	New	+$16.2M	1.79%	14

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

NF Trinity Capital's GILD Position: Q1 2019 in Review

NF Trinity Capital held its Gilead Sciences (GILD) position steady in Q1 2019 at 86,959 shares worth $5.65M. The position accounts for 0.9% of the portfolio, ranked #26.

NF Trinity Capital first reported a position in GILD in Q4 2015 and has held it in 14 quarters since. The position peaked at $15.8M in Q4 2015. 1,491 funds tracked by Wall St. Rank hold GILD as of Q1 2019.

NF Trinity Capital held 86,959 shares of Gilead Sciences worth $5.65M as of Q1 2019.
NF Trinity Capital left its Gilead Sciences share count unchanged in Q1 2019.
Gilead Sciences made up 0.9% of NF Trinity Capital's portfolio in Q1 2019, its #26 holding.
NF Trinity Capital first reported a position in Gilead Sciences in Q4 2015 and has held it in 14 quarters since.
NF Trinity Capital's Gilead Sciences position peaked at $15.8M in Q4 2015.
1,491 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2019.

Based on NF Trinity Capital's 13F filing for Q1 2019, filed 10 May 2019.